Selective Chemonucleolysis With Condoliase in Cynomolgus Monkeys.


Journal

Toxicologic pathology
ISSN: 1533-1601
Titre abrégé: Toxicol Pathol
Pays: United States
ID NLM: 7905907

Informations de publication

Date de publication:
07 2020
Historique:
entrez: 8 7 2020
pubmed: 8 7 2020
medline: 27 5 2021
Statut: ppublish

Résumé

Selective chemonucleolytic effects of condoliase, a glycosaminoglycan degrading enzyme, was investigated histopathologically in cynomolgus monkeys. Condoliase was administered once into the lumber intervertebral disc (IVD), and as a comparative control, chymopapain, a proteolytic enzyme, was administered in a similar manner. Histopathological changes of the IVD and the adjacent vertebral body (VB) were examined at 1 to 26 weeks after administration. Major changes induced by condoliase in the IVD were degenerative and necrotic changes in the nucleus pulposus, annulus fibrosus, cartilaginous endplate (CEP), and epiphyseal growth plate (EGP); focal disappearance of the EGP; and neovascularization and ossification of the CEP. Decreased/necrosis of bone marrow cells with new bone formation was observed in the VB. Cellular regeneration in the IVD was observed as a recovery changes on and after week 4. The changes in the IVD and VB subsided at week 26. Chymopapain induced qualitatively similar but more widely extended changes. The degrees of the changes in the IVD and VB were more severe than those of condoliase, and the changes were exacerbated even at week 26. These results indicated that histopathological changes caused by condoliase were less severe and more selective than those by chymopapain.

Identifiants

pubmed: 32633701
doi: 10.1177/0192623320928006
doi:

Substances chimiques

Chymopapain EC 3.4.22.6
Chondroitin ABC Lyase EC 4.2.2.20

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

656-668

Auteurs

Dai Muramatsu (D)

Safety & Pharmacokinetics, Central Research Laboratory, Research & Development, Seikagaku Corporation, Higashiyamato, Tokyo, Japan.

Hiroaki Yamaguchi (H)

Safety & Pharmacokinetics, Central Research Laboratory, Research & Development, Seikagaku Corporation, Higashiyamato, Tokyo, Japan.

Yuka Minamisawa (Y)

Safety & Pharmacokinetics, Central Research Laboratory, Research & Development, Seikagaku Corporation, Higashiyamato, Tokyo, Japan.

Aisuke Nii (A)

Safety & Pharmacokinetics, Central Research Laboratory, Research & Development, Seikagaku Corporation, Higashiyamato, Tokyo, Japan.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH